Published in Stroke on December 24, 2009
Imaging of acute stroke. Nat Rev Neurol (2010) 1.09
Refining the mismatch concept in acute stroke: lessons learned from PET and MRI. J Cereb Blood Flow Metab (2012) 1.07
Quantitative measurements of relative fluid-attenuated inversion recovery (FLAIR) signal intensities in acute stroke for the prediction of time from symptom onset. J Cereb Blood Flow Metab (2012) 1.03
Wake-up stroke and stroke of unknown onset: a critical review. Front Neurol (2014) 0.98
Imaging stroke patients with unclear onset times. Neuroimaging Clin N Am (2011) 0.90
Wake-up stroke: clinical characteristics, imaging findings, and treatment option - an update. Front Neurol (2014) 0.88
Fluid-attenuated inversion recovery hyperintensity in acute ischemic stroke may not predict hemorrhagic transformation. Cerebrovasc Dis (2011) 0.88
A pragmatic approach using magnetic resonance imaging to treat ischemic strokes of unknown onset time in a thrombolytic trial. Stroke (2012) 0.85
Comparative study of the relative signal intensity on DWI, FLAIR, and T2 images in identifying the onset time of stroke in an embolic canine model. Neurol Sci (2014) 0.84
THrombolysis for Acute Wake-up and unclear-onset Strokes with alteplase at 0·6 mg/kg (THAWS) Trial. Int J Stroke (2014) 0.84
Judgment of FLAIR signal change in DWI-FLAIR mismatch determination is a challenge to clinicians. J Neurol (2011) 0.83
Blood glutathione S-transferase-π as a time indicator of stroke onset. PLoS One (2012) 0.81
Early postoperative MRI overestimates residual tumour after resection of gliomas with no or minimal enhancement. Eur Radiol (2011) 0.81
Unwitnessed stroke: impact of different onset times on eligibility into stroke trials. J Stroke Cerebrovasc Dis (2011) 0.81
MRI-guided selection of patients for treatment of acute ischemic stroke. Curr Opin Neurol (2014) 0.80
Association between the perfusion/diffusion and diffusion/FLAIR mismatch: data from the AXIS2 trial. J Cereb Blood Flow Metab (2015) 0.78
DWI intensity values predict FLAIR lesions in acute ischemic stroke. PLoS One (2014) 0.78
What to do With Wake-Up Stroke. Neurohospitalist (2015) 0.78
The usefulness of diffusion-weighted/fluid-attenuated inversion recovery imaging in the diagnostics and timing of lacunar and nonlacunar stroke. Neuroradiology (2014) 0.78
Difficulty of MRI based identification of lesion age by acute infra-tentorial ischemic stroke. PLoS One (2014) 0.76
We are on the clock: MRI as a surrogate marker of lesion age in acute ischemic stroke. Stroke (2009) 0.76
Fasting versus post-challenge triglycerides and pre-existing cavitating lacunes: a berlin "cream & sugar" substudy. Front Neurol (2013) 0.75
Diffusion-weighted imaging-fluid-attenuated inversion recovery mismatch is associated with better neurologic response to intravenous thrombolytic therapy in acute ischemic stroke patients. Clin Exp Emerg Med (2015) 0.75
Are the current MRI criteria using the DWI-FLAIR mismatch concept for selection of patients with wake-up stroke to thrombolysis excluding too many patients? Scand J Trauma Resusc Emerg Med (2015) 0.75
Association Between Time From Stroke Onset and Fluid-Attenuated Inversion Recovery Lesion Intensity Is Modified by Status of Collateral Circulation. Stroke (2016) 0.75
Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol (2008) 3.98
DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4·5 h of symptom onset (PRE-FLAIR): a multicentre observational study. Lancet Neurol (2011) 3.18
Prehospital thrombolysis in acute stroke: results of the PHANTOM-S pilot study. Neurology (2012) 2.60
Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation (2003) 2.59
Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition. Arterioscler Thromb Vasc Biol (2002) 2.54
MRI versus CT-based thrombolysis treatment within and beyond the 3 h time window after stroke onset: a cohort study. Lancet Neurol (2006) 2.42
Granulocyte colony-stimulating factor in patients with acute ischemic stroke: results of the AX200 for Ischemic Stroke trial. Stroke (2013) 2.36
Comparison of CT and CT angiography source images with diffusion-weighted imaging in patients with acute stroke within 6 hours after onset. Stroke (2002) 2.33
Physical activity improves long-term stroke outcome via endothelial nitric oxide synthase-dependent augmentation of neovascularization and cerebral blood flow. Circ Res (2006) 2.21
NADPH oxidase plays a central role in blood-brain barrier damage in experimental stroke. Stroke (2007) 2.13
Smoking-thrombolysis paradox: recanalization and reperfusion rates after intravenous tissue plasminogen activator in smokers with ischemic stroke. Stroke (2013) 2.11
Severe renal impairment is associated with symptomatic intracerebral hemorrhage after thrombolysis for ischemic stroke. Stroke (2013) 2.07
Perfusion-weighted imaging/diffusion-weighted imaging mismatch on MRI can now be used to select patients for recombinant tissue plasminogen activator beyond 3 hours: pro. Stroke (2005) 2.06
Protein kinase CK2 links extracellular growth factor signaling with the control of p27(Kip1) stability in the heart. Nat Med (2008) 1.91
Imaging-based decision making in thrombolytic therapy for ischemic stroke: present status. Stroke (2003) 1.90
Stroke MRI in intracerebral hemorrhage: is there a perihemorrhagic penumbra? Stroke (2003) 1.90
Stroke research priorities for the next decade--A representative view of the European scientific community. Cerebrovasc Dis (2006) 1.75
Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study. Brain (2003) 1.75
Vascular effects of diet supplementation with plant sterols. J Am Coll Cardiol (2008) 1.68
Acute stroke imaging research roadmap. Stroke (2008) 1.66
Acute stroke magnetic resonance imaging: current status and future perspective. Neuroradiology (2009) 1.59
Transient ischemic attacks before ischemic stroke: preconditioning the human brain? A multicenter magnetic resonance imaging study. Stroke (2004) 1.58
Treatment Options for Statin-Associated Muscle Symptoms. Dtsch Arztebl Int (2015) 1.55
Search for a map and threshold in perfusion MRI to accurately predict tissue fate: a protocol for assessing lesion growth in patients with persistent vessel occlusion. Cerebrovasc Dis (2011) 1.53
3 Tesla MRI-detected brain lesions after pulmonary vein isolation for atrial fibrillation: results of the MACPAF study. J Cardiovasc Electrophysiol (2012) 1.52
Fully automated postprocessing carries a risk of substantial overestimation of perfusion deficits in acute stroke magnetic resonance imaging. Cerebrovasc Dis (2011) 1.50
Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin. J Exp Med (2003) 1.47
Acute Stroke Imaging Research Roadmap II. Stroke (2013) 1.47
Roller culture of free-floating retinal slices: a new system of organotypic cultures of adult rat retina. Ophthalmic Res (2006) 1.42
Acute stroke imaging research roadmap. AJNR Am J Neuroradiol (2008) 1.41
Left atrial catheter ablation and ischemic stroke. Stroke (2011) 1.39
Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice. Brain Res (2002) 1.36
Post-stroke depression: mechanisms, translation and therapy. J Cell Mol Med (2012) 1.34
SUMO2/3 conjugation is an endogenous neuroprotective mechanism. J Cereb Blood Flow Metab (2011) 1.32
A multicenter, randomized, double-blind, placebo-controlled trial to test efficacy and safety of magnetic resonance imaging-based thrombolysis in wake-up stroke (WAKE-UP). Int J Stroke (2013) 1.29
Inhibition of the alternative complement activation pathway in traumatic brain injury by a monoclonal anti-factor B antibody: a randomized placebo-controlled study in mice. J Neuroinflammation (2007) 1.24
Telestroke ambulances in prehospital stroke management: concept and pilot feasibility study. Stroke (2012) 1.24
Inhibition of histone deacetylation protects wildtype but not gelsolin-deficient mice from ischemic brain injury. Exp Neurol (2007) 1.21
Stroke and myocardial infarction: a comparative systematic evaluation of gender-specific analysis, funding and authorship patterns in cardiovascular research. Cerebrovasc Dis (2011) 1.20
AXIS: a trial of intravenous granulocyte colony-stimulating factor in acute ischemic stroke. Stroke (2010) 1.19
Mobile computed tomography: prehospital diagnosis and treatment of stroke. Curr Opin Neurol (2015) 1.18
Neuroprotective effects of atorvastatin against glutamate-induced excitotoxicity in primary cortical neurones. J Neurochem (2005) 1.17
Pharmacological complement inhibition at the C3 convertase level promotes neuronal survival, neuroprotective intracerebral gene expression, and neurological outcome after traumatic brain injury. Exp Neurol (2006) 1.14
Temporal retinal nerve fiber loss in patients with spinocerebellar ataxia type 1. PLoS One (2011) 1.14
Withdrawal of statin treatment abrogates stroke protection in mice. Stroke (2003) 1.13
Phosphatidylinositol 3-Akt-kinase-dependent phosphorylation of p21(Waf1/Cip1) as a novel mechanism of neuroprotection by glucocorticoids. J Neurosci (2007) 1.12
Folate deficiency induces neurodegeneration and brain dysfunction in mice lacking uracil DNA glycosylase. J Neurosci (2008) 1.10
Thalamic sensory strokes with and without pain: differences in lesion patterns in the ventral posterior thalamus. J Neurol Neurosurg Psychiatry (2012) 1.10
Essential role of interleukin-6 in post-stroke angiogenesis. Brain (2012) 1.09
Folic acid, neurodegenerative and neuropsychiatric disease. Curr Mol Med (2009) 1.09
The biennial cycle of respiratory syncytial virus outbreaks in Croatia. Virol J (2008) 1.08
Prospective study on the mismatch concept in acute stroke patients within the first 24 h after symptom onset - 1000Plus study. BMC Neurol (2009) 1.08
Immune responses after acute ischemic stroke or myocardial infarction. Int J Cardiol (2010) 1.08
The ectonucleotidase cd39/ENTPDase1 modulates purinergic-mediated microglial migration. Glia (2008) 1.08
Neuronal gelsolin prevents apoptosis by enhancing actin depolymerization. Mol Cell Neurosci (2004) 1.07
Intravenous rosuvastatin for acute stroke treatment: an animal study. Stroke (2007) 1.05
Modulation of fate determinants Olig2 and Pax6 in resident glia evokes spiking neuroblasts in a model of mild brain ischemia. Stroke (2010) 1.04
Chronic heart failure and ischemic stroke. Stroke (2011) 1.04
Quantitative measurements of relative fluid-attenuated inversion recovery (FLAIR) signal intensities in acute stroke for the prediction of time from symptom onset. J Cereb Blood Flow Metab (2012) 1.03
Fluid-attenuated inversion recovery images and stroke outcome after thrombolysis. Stroke (2011) 1.03
Effects of the PDE5-inhibitor vardenafil in a mouse stroke model. Brain Res (2009) 1.03
Safety of Tirofiban in acute Ischemic Stroke: the SaTIS trial. Stroke (2011) 1.03
Identifying the perfusion deficit in acute stroke with resting-state functional magnetic resonance imaging. Ann Neurol (2013) 1.03
Characterization of long-term functional outcome in a murine model of mild brain ischemia. J Neurosci Methods (2013) 1.01
HMG-CoA reductase inhibition causes neurite loss by interfering with geranylgeranylpyrophosphate synthesis. J Neurochem (2004) 1.01
The neurovascular unit as a selective barrier to polymorphonuclear granulocyte (PMN) infiltration into the brain after ischemic injury. Acta Neuropathol (2012) 1.00
Refinement of the magnetic resonance diffusion-perfusion mismatch concept for thrombolytic patient selection: insights from the desmoteplase in acute stroke trials. Stroke (2012) 1.00
Hyperintense acute reperfusion marker on FLAIR is not associated with early haemorrhagic transformation in the elderly. Eur Radiol (2010) 0.99
In vivo imaging of the inflammatory receptor CD40 after cerebral ischemia using a fluorescent antibody. Stroke (2008) 0.99
Fas/CD95 regulatory protein Faim2 is neuroprotective after transient brain ischemia. J Neurosci (2011) 0.99
Impact of actin filament stabilization on adult hippocampal and olfactory bulb neurogenesis. J Neurosci (2010) 0.99
White matter lesion severity in mild acute ischemic stroke patients and functional outcome after 1 year. Stroke (2012) 0.98
Assessing post-stroke behavior in mouse models of focal ischemia. J Cereb Blood Flow Metab (2012) 0.98
Clinical and radiological courses do not differ between fluid-attenuated inversion recovery-positive and negative patients with stroke after thrombolysis. Stroke (2010) 0.97